<DOC>
	<DOC>NCT00902304</DOC>
	<brief_summary>This study will assess the efficacy of an intensive blood pressure management strategy compared to usual care in a primary care (general practice) setting.</brief_summary>
	<brief_title>Valsartan Intensified Primary Care Reduction of Blood Pressure Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine, Valsartan Drug Combination</mesh_term>
	<criteria>newly diagnosed or currently treated hypertensive patients who have not attained their blood pressure target and require active pharmacological treatment as recommended by the local guidelines as judged by the general practitioner significantly elevated blood pressure (severe hypertension) requiring 3 or more antihypertensive drugs severe kidney disease or dialyses clinical diagnosis requiring concomitant therapy with antihypertensive treatment that would be outside the therapies allowed under study protocol Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>valsartan</keyword>
</DOC>